A Comparative Placebo-Controlled Clinical Trial of the Efficacy and Safety of Interferon β-1a Formulations for S.C. Administration in Patients with Remitting Multiple Sclerosis: First-Year Results

A. N. Boiko; L. P. Bosenko; V. V. Vasilovskii; L. I. Volkova; M. N. Zakharova; S. V. Kotov; E. V. Lekomtseva; T. I. Negrich; E. V. Parshina; O. P. Patrusheva; S. V. Prokopenko; D. V. Sazonov; P. V. Timchenko; Yu. V. Trinitatskii; F. A. Khabirov; M. Ya. Khavunka; L. V. Chichanovskaya; M. A. Sherman; Yu. N. Lin’kova; A. V. Zinkina-Orikhan; K. B. Tursunova